Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Stefano Benenati"'
Publikováno v:
Open Heart, Vol 10, Iss 2 (2023)
Percutaneous coronary intervention (PCI) is widely adopted to treat chronic coronary artery disease. Numerous randomised trials have been conducted to test whether PCI may provide any prognostic advantage over oral medical therapy (OMT) alone, withou
Externí odkaz:
https://doaj.org/article/475244f6eeb74275a71abccf949faeb5
Autor:
Filippo Luca Gurgoglione, Luigi Vignali, Rocco Antonio Montone, Riccardo Rinaldi, Giorgio Benatti, Emilia Solinas, Antonio Maria Leone, Domenico Galante, Gianluca Campo, Simone Biscaglia, Italo Porto, Stefano Benenati, Giampaolo Niccoli
Publikováno v:
Life, Vol 14, Iss 3, p 292 (2024)
Coronary vasomotor disorders (CVD) are characterized by transient hypercontraction of coronary vascular smooth muscle cells, leading to hypercontraction of epicardial and/or microvascular coronary circulation. CVDs play a relevant role in the pathoge
Externí odkaz:
https://doaj.org/article/851db1eb1b514759bf4bb9639885846b
Autor:
Stefano Benenati, Francesco Gallo, Won-keun Kim, Arif A. Khokhar, Tobias Zeus, Stefan Toggweiler, Roberto Galea, Federico De Marco, Antonio Mangieri, Damiano Regazzoli, Bernhard Reimers, Luis Nombela-Franco, Marco Barbanti, Ander Regueiro, Tommaso Piva, Josep Rodes-Cabau, Italo Porto, Antonio Colombo, Francesco Giannini, Alessandro Sticchi
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 11, Iss 1, p 33 (2024)
Background: Current European guidelines support transcatheter aortic valve implantation (TAVI) in intermediate-to-low-risk patients ≥75 years-old, but its prognostic relevance is unknown. Methods: Intermediate-to-low-risk (The Society of Thoracic S
Externí odkaz:
https://doaj.org/article/abdaf001cdc7407a99fbe7f339debdae
Autor:
Samuel B. Wopperer, Rafail Kotronias, Federico Marin, Stefano Benenati, Francesco Della Mora, Leonardo Portolan, Adrian P. Banning, Giovanni Luigi De Maria
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
The treatment of coronary artery disease (CAD) has advanced significantly in recent years due to improvements in medical therapy and percutaneous or surgical revascularization. However, a persistent obstacle in the percutaneous management of CAD is c
Externí odkaz:
https://doaj.org/article/1d758676019842efb69c508e91ff50a9
Autor:
Stefano Giovinazzo, Luca Carmisciano, Matteo Toma, Stefano Benenati, Daniela Tomasoni, Maria Pia Sormani, Italo Porto, Marco Canepa, Michele Senni, Marco Metra, Pietro Ameri
Publikováno v:
ESC Heart Failure, Vol 8, Iss 5, Pp 3547-3556 (2021)
Abstract Aims We systematically reviewed the European real‐world evidence (RWE) about sacubitril‐valsartan for heart failure with reduced ejection fraction. Methods and results Twenty‐one articles, including 16 952 subjects, were identified unt
Externí odkaz:
https://doaj.org/article/04f378d889c54be9a417bb6b98c29fc3
Autor:
Porto, Luca Barca, Giuseppe Mascia, Paolo Di Donna, Paolo Sartori, Daniele Bianco, Roberta Della Bona, Stefano Benenati, Andrea Carlo Merlo, Antonia Luisa Buongiorno, Niki Kaufman, Antonio Vena, Matteo Bassetti, Italo
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 13; Pages: 4543
Background: The gold standard for the treatment of cardiac implantable electronic devices (CIEDs)-related infection and lead malfunction is transvenous lead extraction (TLE). To date, the risk of mortality directly related to TLE procedures is relati
Autor:
Giuseppe Mascia, Lia Crotti, Antonella Groppelli, Marco Canepa, Andrea Carlo Merlo, Stefano Benenati, Paolo Di Donna, Roberta Della Bona, Davide Soranna, Antonella Zambon, Italo Porto, Iacopo Olivotto, Gianfranco Parati, Michele Brignole, Franco Cecchi
Publikováno v:
International Journal of Cardiology. 357:88-94
Aims: To describe the proportion of patients with syncope among those affected by hypertrophic cardiomyopathy (HCM) and the relevance of syncope as risk factor for sudden cardiac death and life-threatening arrhythmic events. Method and results: Syste
Autor:
Stefano Benenati, Francesco Gallo, Won-keun Kim, Arif A Khokhar, Tobias Zeus, Stefan Toggweiler, Roberto Galea, Federico De Marco, Antonio Mangieri, Damiano Regazzoli, Bernhard Reimers, Luis Nombela-Franco, Marco Barbanti, Ander Regueiro, Tommaso Piva, Josep Rodes-Cabau, Italo Porto, Antonio Colombo, Francesco Giannini, Alessandro Sticchi
Background: Current European guidelines support transcatheter aortic valve implantation (TA-VI) in intermediate to low-risk patients ≥75 years-old but its prognostic relevance is unknown. Methods: Intermediate-to-low-risk (Society of Thoracic Surge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0bf0531a24ab01c90599d9c01e7ee8f
https://doi.org/10.20944/preprints202305.2019.v1
https://doi.org/10.20944/preprints202305.2019.v1
Publikováno v:
Cardiovascular Revascularization Medicine.
Publikováno v:
European Heart Journal - Cardiovascular Pharmacotherapy.